Form 8-K - Current report:
SEC Accession No. 0001104659-14-081672
Filing Date
2014-11-18
Accepted
2014-11-18 16:15:42
Documents
19
Period of Report
2014-11-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-24684_18k.htm 8-K 23052
2 EX-99.1 a14-24684_1ex99d1.htm EX-99.1 37952
3 GRAPHIC g246841mmi001.gif GRAPHIC 45663
4 GRAPHIC g246841mmi002.gif GRAPHIC 115697
5 GRAPHIC g246841mmi003.gif GRAPHIC 36880
6 GRAPHIC g246841mmi004.gif GRAPHIC 64788
7 GRAPHIC g246841mmi005.gif GRAPHIC 60369
8 GRAPHIC g246841mmi006.gif GRAPHIC 69000
9 GRAPHIC g246841mmi007.jpg GRAPHIC 70386
10 GRAPHIC g246841mmi008.gif GRAPHIC 60164
11 GRAPHIC g246841mmi009.jpg GRAPHIC 58078
12 GRAPHIC g246841mmi010.gif GRAPHIC 42853
13 GRAPHIC g246841mmi011.gif GRAPHIC 54277
14 GRAPHIC g246841mmi012.jpg GRAPHIC 54393
15 GRAPHIC g246841mmi013.gif GRAPHIC 73561
16 GRAPHIC g246841mmi014.gif GRAPHIC 87737
17 GRAPHIC g246841mmi015.gif GRAPHIC 34609
18 GRAPHIC g246841mmi016.gif GRAPHIC 45148
19 GRAPHIC g246841mmi017.gif GRAPHIC 95181
  Complete submission text file 0001104659-14-081672.txt   1537241
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36033 | Film No.: 141232080
SIC: 2834 Pharmaceutical Preparations